 |
|
Vaginal Misoprostol Administered 1, 2, or 3 Days After Mifepristone for Early Medical Abortion
A Randomized Trial
Eric A. Schaff, MD;
Stephen L. Fielding, PhD;
Carolyn Westhoff, MD;
Charlotte Ellertson, PhD;
Steven H. Eisinger, MD;
Lisa S. Stadalius, MS, RNC;
Lisa Fuller, MD
JAMA. 2000;284:1948-1953.
Context The conventional timing of misoprostol administration after mifepristone for medical abortion is 2 days, but more flexible intervals, which may make the regimen more convenient, have not been studied.
Objective To determine whether vaginal misoprostol administered 1, 2, or 3 days after mifepristone influences safety or effectiveness for abortion at up to 56 days' gestation.
Design Prospective, randomized, open-label trial conducted from March 1998 to June 1999.
Setting Sixteen US primary care and referral abortion facilities.
Patients A total of 2295 healthy patients aged 18 years or older who were 56 or fewer days pregnant. Forty (1.7%) were lost to follow-up.
Interventions Patients received 200 mg of oral mifepristone and were randomly assigned to self-administer 800 µg of vaginal misoprostol at home 1 (n = 745), 2 (n = 778), or 3 (n = 772) days later. Women returned to the clinic up to 8 days after mifepristone for ultrasonographic evaluation. A second dose of misoprostol was administered if the abortion was not complete. Patients with continuing pregnancy, excessive bleeding, or retained pregnancy tissue 5 weeks later received an aspiration curettage.
Main Outcome Measures Effectiveness of the procedure (ie, a complete medical abortion without surgical intervention), adverse effects, acceptability of the procedure based on patient questionnaires, reasons for surgical intervention, and adverse outcomes, compared among the study groups.
Results Of the 2255 women completing follow-up, complete medical abortion rates were 98% (95% confidence interval [CI], 97%-99%) among those using misoprostol after 1 day, 98% (95% CI, 97%-99%) for those using misoprostol after 2 days, and 96% (95% CI, 95%-97%) among those using misoprostol after 3 days. Fifty-five subjects aborted before taking misoprostol, 9 had early surgery, and 103 did not take misoprostol on their assigned day. No blood transfusions were required. Cramping and nausea were the most common adverse effects reported, with similar percentages of patients in all 3 groups reporting such effects. Thirteen unexpected or serious adverse events occurred: 6 in those using misoprostol after 1 day; 4 in those using it after 2 days; and 3 in those using it after 3 days. Nearly all women (>90%) found the procedure to be acceptable.
Conclusions Our results suggest that vaginal misoprostol, 800 µg, can be used from 1 to 3 days after mifepristone, 200 mg, for early medical abortion, and need not be administered strictly 48 hours after mifepristone.
Author Affiliations: Reproductive Health Program, Department of Family Medicine, University of Rochester School of Medicine, Rochester, NY (Drs Schaff, Fielding, Eisinger, and Fuller and Ms Stadalius); Department of Obstetrics and Gynecology and School of Public Health, Columbia University, New York, NY (Dr Westhoff); and the Population Council of New York, New York, NY (Dr Ellertson).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
October 18, 2000
JAMA. ;284():1993-1994.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion
Chai et al.
Hum Reprod 2009;24:320-324.
ABSTRACT
| FULL TEXT
Medical Liability Insurance as a Barrier to the Provision of Abortion Services in Family Medicine
Dehlendorf and Grumbach
AJPH 2008;98:1770-1774.
ABSTRACT
| FULL TEXT
Mifepristone does not induce cervical softening in non-pregnant women
Ben-Chetrit et al.
Hum Reprod 2004;19:2372-2376.
ABSTRACT
| FULL TEXT
Social Context and the Experience of a Sample of U.S. Women Taking RU-486 (Mifepristone) for Early Abortion
Fielding and Schaff
Qual Health Res 2004;14:612-627.
ABSTRACT
Induced Abortion: An Overview for Internists
Grimes and Creinin
ANN INTERN MED 2004;140:620-626.
ABSTRACT
| FULL TEXT
Prediction of late failure after medical abortion from serial {beta}-hCG measurements and ultrasonography
Rorbye et al.
Hum Reprod 2004;19:85-89.
ABSTRACT
| FULL TEXT
Medical Abortion in Family Practice: A Case Series
Prine et al.
J Am Board Fam Med 2003;16:290-295.
ABSTRACT
| FULL TEXT
Emergency Contraception
Grimes and Raymond
ANN INTERN MED 2002;137:180-189.
ABSTRACT
| FULL TEXT
Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation
Bartley et al.
Hum Reprod 2001;16:2098-2102.
ABSTRACT
| FULL TEXT
Misoprostol and Pregnancy
Goldberg et al.
NEJM 2001;344:38-47.
FULL TEXT
|
